Cargando…
Establishment and Validation of a Model for Disease-Free Survival Rate Prediction Using the Combination of microRNA-381 and Clinical Indicators in Patients with Breast Cancer
OBJECTIVE: We have found that miR-381 can regulate the proliferation of breast cancer cells by regulating TWIST protein, it can serve as a potential marker for the tumor progression. Thus, we herein establishment and validation of a model for predicting disease progression in patients with breast ca...
Autores principales: | Shen, Jun, Wang, Meng, Li, Fan, Yan, Huanhuan, Wang, Rui, Zhou, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719690/ https://www.ncbi.nlm.nih.gov/pubmed/36475295 http://dx.doi.org/10.2147/BCTT.S383121 |
Ejemplares similares
-
MicroRNA‐381 in human cancer: Its involvement in tumour biology and clinical applications potential
por: Sha, Huanhuan, et al.
Publicado: (2022) -
MicroRNA-381 Regulates Chondrocyte Hypertrophy by Inhibiting Histone Deacetylase 4 Expression
por: Chen, Weishen, et al.
Publicado: (2016) -
Serum microRNA-381: A Potential Marker for Early Diagnosis of Gastric Cancer
por: Li, Ye, et al.
Publicado: (2019) -
Validation of a Disease-Free Survival Prediction Model Using UBE2C and Clinical Indicators in Breast Cancer Patients
por: Shen, Jun, et al.
Publicado: (2023) -
MicroRNA-381 inhibits the metastasis of gastric cancer by targeting TMEM16A expression
por: Cao, Qinghua, et al.
Publicado: (2017)